Cargando…
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
Metastatic castration resistant prostate cancer (mCRPC) is still the lethal stage for the whole spectrum of prostate cancer disease. Even though different treatment options have been introduced in the last decade with a significant survival improvement for this population, a lack of more reliable pr...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564750/ https://www.ncbi.nlm.nih.gov/pubmed/37816781 http://dx.doi.org/10.1038/s41598-023-43937-7 |